ELDN earnings date and last-quarter result: next report 2026-08-13, last quarter beat, P/E -4.28. Updated 2026-07-23.
Eledon Pharmaceuticals (ELDN) Research Hub
Eledon Pharmaceuticals (ELDN) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 2.21 USD (-3.91%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -4.28, market cap 0.23B. This hub links to the full technical, earnings and options research available for ELDN.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 2.21 USD (-3.91%) |
| 52-week range | 2.11 USD – 4.49 USD |
| Trend regime | Range |
| 14-day RSI | 33.8 (Bearish) |
| Trailing P/E | -4.28 |
| Market cap | 0.23B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-13 |
Available research for ELDN
Covered Call on ELDN: how it works, illustrative setup around the real 2.21 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on ELDN: how it works, illustrative setup around the real 2.21 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on ELDN: how it works, illustrative setup around the real 2.21 USD price, max profit/loss, breakeven and when to use it. Educational.
ELDN technical analysis: range, last 2.21 USD, RSI 33.8, 52w range 2.11 USD–4.49 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is ELDN in?
Eledon Pharmaceuticals (ELDN) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is ELDN in an uptrend or downtrend?
As of 2026-10-26, ELDN is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is ELDN's trailing P/E ratio?
ELDN's trailing P/E is -4.28, with a market cap of 0.23B. See the earnings research page for full valuation detail.
When does ELDN next report earnings?
ELDN is next scheduled to report earnings on 2026-08-13.